New schizophrenia drug tested in major clinical trial
NCT ID NCT01625000
Summary
This study tested whether a medication called MP-214 could help control symptoms in people experiencing a schizophrenia flare-up. Researchers compared the drug against a placebo in 512 patients over 6 weeks to see if it reduced symptoms and was safe to use. The trial measured changes in overall schizophrenia symptoms using standard rating scales.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Sapporo, Hokkaido, Japan
-
Study site
Seoul, South Korea
-
Study site
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.